Skip to Content

Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Medical

The Holidays Can Pose Hazards to Your Pet's Health

While you revel in the decorations and good food of the holiday season, there are dangers lurking in the tinsel and treats that can pose threats to your beloved pet. One veterinarian offers suggestions to maintain your pet safety. "Keep your pet from chewing or ingesting ornaments, holiday lights, electric wire and ribbons, to prevent gastrointestinal...

Posted 3 days ago in New Drug Approvals

FDA Approves Ixifi (infliximab-qbtx), a Biosimilar to Remicade

Pfizer Inc. (NYSE:PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) has approved Ixifi (PF-06438179, infliximab-qbtx), a chimeric human-murine monoclonal antibody (mAb) against tumor necrosis factor, as a biosimilar to Remicade® (infliximab)* for all eligible indications of the reference product.1 The FDA has...

Posted 3 days ago in Clinical Trials

Talazoparib Significantly Extends Progression-Free Survival in Phase 3 EMBRACA Trial of Patients with Metastatic Breast Cancer

Pfizer Inc. (NYSE:PFE) today announced that the Phase 3 EMBRACA trial in patients with germline (inherited) BRCA1/2-positive (gBRCA+) locally advanced and/or metastatic breast cancer (MBC) demonstrated superior progression-free survival (PFS) in patients treated with talazoparib, compared to patients who received physician’s choice standard of care...

Posted 2 days ago in Medical

Health Tip: Make Your Home Safer For People With Alzheimer's

-- It's important to keep your home as safe as possible, especially if a loved one has Alzheimer's disease. The U.S. National Institute on Aging offers these suggestions: Clearly post emergency numbers and your home address near any telephone. Install secure locks on all outside doors and windows. Install alarms that notify you when a door or...

Posted 2 days ago in Medical

Health Highlights: Dec. 15, 2017

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Cancer Risk From Fibroid-Removal Tool Still Too High, FDA Says A new review of recent studies confirms its previous estimates of the risk of spreading uterine cancer after laparoscopic power morcellation to have uterine growths (fibroids) removed,...

Posted 2 days ago in Medical

Health Tip: Give Your Dog Safe Treats

-- Fido can become quite sick from unsafe treats, the U.S. Food and Drug Administration warns. Your dog may have a bone to pick with you if a bad treat leads to stomach or bowel obstruction, choking, mouth wounds, vomiting, diarrhea or internal bleeding, the FDA says. In some cases, a bad treat can lead to death. The FDA suggests how to keep your...

Posted 2 days ago in Medical

Today Is the Deadline for Obamacare 2018

Today marks the end of the shortened sign-up period for most Americans to buy health insurance through the federal Affordable Care Act (Obamacare) marketplace. Dec. 15 is the last enrollment day for people living in 39 states served by the HealthCare.gov website. At the site, people can pick a health plan, choose a new plan, and also find out if they...

Posted 2 days ago in Medical

Too Much Takeout Food Threatens Kids' Health

You can't beat the convenience of ordering out, but a steady diet of takeout food could raise your child's risk of heart disease and diabetes later in life. That's the word from British researchers who looked at the eating habits and health of more than 1,900 ethnically diverse children in England, ages 9 and 10. The kids were shown photos of common...

Posted 2 days ago in Medical

Excess Weight May Raise Rosacea Risk

The skin disorder rosacea should be added to the list of chronic diseases linked to obesity, researchers report. Their large new study found that the risk for rosacea increases among women as weight rises. The researchers reviewed the records of nearly 90,000 U.S. women, tracked over 14 years. They found a 48 percent higher likelihood of rosacea among...

Posted 2 days ago in Medical

5 Ways to Avoid Holiday Weight Gain

It's fun to celebrate the holidays, but week after week of festivities can add up to weight gain if you aren't careful. Pre-planning is key if you don't want to start next year with an even bigger weight loss goal. This is the perfect time of year to step up exercise. Adding 15 minutes a day every day can help burn off some of the extra calories...

Read more news...

Recently added consumer and prescribing information: Ozempic, Juluca, Hemlibra, Prevymis, Fasenra, Calquence, Yescarta, Verzenio, Trelegy Ellipta, Solosec

Posted in Blog

Drugs.com Receives eHealthcare Leadership Silver Award

We are proud to announce that Drugs.com has been awarded a Silver Award for “Best Consumer General Health Site” in the 2017 eHealthcare Leadership Awards. Jane Weber Brubaker, chair of the eHealthcare Leadership Awards, notes that “Winners range from small and large healthcare provider organizations, to business-to-business and medical device companies, but they share these […]

Posted in Blog

Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study

The team at Drugs.com is humbled and heartened to have been recognized as the ‘Health Information Website Brand of the Year‘ in the 2017 Harris Poll EquiTrend Study. The annual Harris Poll EquiTrend® Study measures and compares a brand’s health over time and against key competitors. Other categories measured include travel, financial, automotive and entertainment. […]

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

See more blog posts or follow us on twitter.